KAPA - Kairos Pharma, LTD.

0.9676
-0.172   -17.817%

Share volume: 211,183
Last Updated: 04-08-2025
Pharmaceutical Products/Pharmaceutical Preparations: 0.05%

PREVIOUS CLOSE
CHG
CHG%
$1.14
-0.17
-0.15%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
8%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 20%
Performance
5 Days
-8.72%
1 Month
5.17%
3 Months
-21.97%
6 Months
-21.97%
1 Year
-21.97%
2 Year
-21.97%
Key data
Stock price
$0.97
P/E Ratio 
N/A
DAY RANGE
$0.95 - $1.12
EPS 
N/A
52 WEEK RANGE
$0.85 - $1.40
52 WEEK CHANGE
-$21.97
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
0.000
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
04-15-2025
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$207,986
AVERAGE 30 VOLUME 
$125,144
Company detail
CEO: John S. Yu
Region: US
Website: kairospharma.com
Employees: 0
IPO year: 2024
Issue type:
Market: NYSE American
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

We are a clinical-stage biopharmaceutical company advancing therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance. Our registered corporate address is 2355 Westwood Blvd., #139, Los Angeles, California.

Recent news
loading